Dotters-Katz S K, Myrick O, Smid M, Manuck T A, Boggess K A, Goodnight W
Division of Maternal-Fetal Medicine, Duke University, Durham, NC, USA.
Department of Obstetrics and Gynecology, Columbia University, USA.
J Neonatal Perinatal Med. 2017;10(4):431-437. doi: 10.3233/NPM-16165.
To measure the effect of prophylactic antibiotics given at time of previable prelabor rupture of membranes (PROM) on latency.
Single center, retrospective cohort study of singleton pregnancies with previable (<23 0/7weeks) PROM. Antibiotics were given at clinician discretion. The primary outcome was latency, defined as duration of time between previable PROM and delivery. Secondary outcomes included delivery at ≥ 23weeks, infant survival, and maternal morbidity. Bivariate analysis compared maternal covariates between women who did and did not receive antibiotics. Antibiotic effect on latency was modeled using a Cox proportional hazards ratio.
213 women with previable PROM were identified; 77 (36%) remained pregnant and thus were included in this analysis. Forty (52%) of 77 received antibiotics. Compared to women who did not receive antibiotics, those who did had PROM at a later median (IQR) estimated gestational age, EGA, (22.2weeks [20.7, 22.5] vs. 19.3weeks [18, 20.7], p < 0.01). Median (IQR) latency was not different between women who did and did not receive antibiotics (2.2 [0.7, 3.9] vs. 1.5 [0.5, 4.6] weeks, p = 0.49). More infants survived to discharge among women who received antibiotics compared to those who did not [17(43%) vs. 3(8%), p < 0.01]. When adjusted for EGA at PROM, antibiotics were associated with longer latency (HR 0.57 [95% CI 0.33, 0.97], p = 0.01). Antibiotic use was not associated with differences in maternal morbidity.
After adjusting for EGA at PROM, antibiotic receipt was associated with longer latency. Larger prospective studies are needed to define the utility of prophylactic antibiotics in previable PROM.
测量在孕23周前胎膜早破(PROM)时给予预防性抗生素对潜伏期的影响。
对单胎妊娠且孕23周前胎膜早破的病例进行单中心回顾性队列研究。抗生素的使用由临床医生决定。主要结局是潜伏期,定义为孕23周前胎膜早破至分娩的时间。次要结局包括孕23周及以后分娩、婴儿存活及产妇发病率。双变量分析比较了接受和未接受抗生素治疗的女性之间的产妇协变量。使用Cox比例风险比模型分析抗生素对潜伏期的影响。
共识别出213例孕23周前胎膜早破的女性;其中77例(36%)继续妊娠,因此纳入本分析。77例中有40例(52%)接受了抗生素治疗。与未接受抗生素治疗的女性相比,接受治疗的女性胎膜早破时的估计孕周中位数(四分位间距)更高(22.2周[20.7, 22.5] vs. 19.3周[18, 20.7],p<0.01)。接受和未接受抗生素治疗的女性潜伏期中位数(四分位间距)无差异(2.2周[0.7, 3.9] vs. 1.5周[0.5, 4.6],p=0.49)。与未接受抗生素治疗的女性相比,接受治疗的女性中有更多婴儿存活至出院[17例(43%) vs. 3例(8%),p<0.01]。调整胎膜早破时的孕周后,抗生素与更长的潜伏期相关(风险比0.57[95%置信区间0.33, 0.97],p=0.01)。抗生素的使用与产妇发病率差异无关。
调整胎膜早破时的孕周后,接受抗生素治疗与更长的潜伏期相关。需要开展更大规模的前瞻性研究来确定预防性抗生素在孕23周前胎膜早破中的作用。